News

MakeMyTrip's Growth Journey: Analysts Show Strong Confidence

MakeMyTrip's Growth Journey: Analysts Show Strong Confidence

MakeMyTrip's Growth Potential Remains Bright

Goldman Sachs recently reaffirmed a Buy rating for MakeMyTrip (NASDAQ:MMYT), keeping a price target of $112.00. The firm highlighted the remarkable financial performance of MakeMyTrip, which reported a 23% increase in revenue year-on-year for the fiscal year 2025's second quarter. This surge slightly exceeded Goldman Sachs' estimates, showcasing the company’s robust business model amid seasonal challenges typical in the travel industry.

Travel Demand on the Rise

MakeMyTrip's recent earnings statements reveal a solid demand for travel, with no significant downturn affecting operations. Notably, international travel showed impressive resilience, achieving a remarkable growth rate of over 40% year-on-year. Goldman Sachs predicts strong, sustainable growth potential in this segment, indicating a favorable trajectory for MakeMyTrip's future business prospects.

Domestic Air Segment Resilience

In addition to international travel, MakeMyTrip's domestic air segment has outpaced overall industry growth, illustrating the company’s ability to withstand competitive pressures, including the shift towards direct airline bookings. Goldman Sachs maintains its forecast for about 20% annual revenue growth in the coming years, which adds to the optimistic outlook regarding the company's robust performance.

EBITDA Projections Show Promise

The firm's expectations indicate a compound annual growth rate (CAGR) of over 30% in EBITDA for MakeMyTrip from fiscal year 2024 to 2027. Despite being valued with a price-to-earnings (P/E) ratio of 60 times the forecasted fiscal year 2026 earnings, which is notably higher than the average for both global travel firms and other Indian web-based companies, Goldman Sachs does not foresee an imminent reassessment of MakeMyTrip's market multiples. This confidence is attributed to the firm’s strong growth forecasts and a supportive competitive landscape.

Confident Valuation Metrics

The valuation of MakeMyTrip, assessed on a growth-adjusted basis with a price-to-earnings growth (PEG) ratio standing at 1.5 times, places it in a favorable position within Goldman Sachs’ coverage spectrum. The continued reiteration of their Buy rate, along with the targeted 12-month price point of $112, underscores belief in the company's continued growth trajectory and overall market performance.

Significant Second-Quarter Achievements

MakeMyTrip Limited recently reported explosive growth in its second-quarter results for fiscal 2025. The company achieved a 24.3% increase in gross bookings year-over-year, culminating in a value of $2.3 billion, while adjusted operating profit exhibited a 33% rise to $37.5 million. Such positive trends stemmed from the company's strategic expansion and the incorporation of AI-driven efficiencies.

Innovations Fueling Growth

Both international air ticketing and hotel revenues have enjoyed substantial growth, with air ticketing climbing over 39% and hotel revenue increasing by 62% year-on-year. Moreover, MakeMyTrip has broadened its hotel offerings to encompass 165 countries and has made headway in the corporate travel sector, alongside initiatives aimed at boosting customer loyalty. The introduction of a new loyalty program and a co-branded credit card in collaboration with ICICI Bank have also contributed to this growth narrative.

Positive Outlook Despite Challenges

While summer storms posed a temporary challenge to demand levels in recent reports, early indicators for the upcoming holiday season showcase an optimistic outlook. The integration of GenAI technology promises to enhance operational efficiency and improve customer experiences, with meaningful financial benefits expected in forthcoming quarters. Although international travel may face short-term obstacles due to geopolitical uncertainties, MakeMyTrip stands robust with over $700 million in cash reserves and plans for share buyback initiatives.

Frequently Asked Questions

What recent rating did Goldman Sachs give MakeMyTrip?

Goldman Sachs maintained a Buy rating for MakeMyTrip with a price target of $112.00.

What growth did MakeMyTrip report in its most recent quarter?

The company reported a 23% year-over-year increase in revenue for the second quarter of fiscal 2025.

What factors contribute to MakeMyTrip’s growth outlook?

Strong travel demand, particularly in international air travel, and successful business strategies like AI enhancements contribute to its growth.

How does MakeMyTrip’s performance compare to the travel industry?

MakeMyTrip's domestic air segment has outperformed industry trends, showing resilience against competitive pressures.

What recent innovations has MakeMyTrip introduced?

The company has launched a new loyalty program, co-branded credit card, and expanded its offerings in international travel and corporate segments.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

2026 Beauty Icon Awards: Honoring Black Beauty Excellence

Updated Category News Views 7

When it comes to honoring legacy and future within the Black beauty industry, the 2026 Beauty Icon Awards seem ready to steal the spotlight. Set to take place on October 10th at Atlanta's Riverside EpiCenter, this gathering is more than just a fancy shindig – it's a tribute to Black beauty's massive influence on culture and commerce. Celebrating Pioneers and Innovators...

Continue Reading
Aranscia Joins Northside Hospital in Precision Oncology

Updated Category News Views 7

Unifying Molecular Diagnostics for Better Cancer Care In the chaos of today’s healthcare, Aranscia is aiming to rewrite the book on how we handle cancer diagnostics by teaming up with Northside Hospital Cancer Institute. Now, instead of fumbling through disconnected systems, they plan to glue the pieces together with a blend of their own and borrowed tech. This...

Continue Reading
ABnet Touts Anthropic's AI in Corporate Evolution

Updated Category News Views 7

Changing the AI Game in Enterprise At the heart of Tel Aviv-Yafo, ABnet Communication Ltd. is spitting fire, and this ain't your average tech chatter. They're drilling right down to the marrow, stressing just how much Anthropic—kingpin of advanced AI for enterprises—is shaking up the corporate shell game. Today’s conversation leans heavily into autonomous AI, and...

Continue Reading
Saudi Arabia Unveils CEER's Flagship Electric Vehicles

Updated Category News Views 4

CEER's Ambitious Leap in Automotive Innovation There's a new kid on the automotive block, and it's making some serious noise. Straight out of Jeddah, CEER has just taken the wraps off their flagship electric sedan and SUV, dubbed the EXOBOT. No small beans here—this is a full-throttle, Saudi-driven pitch into the global automotive circus. And why not? There's oil in...

Continue Reading
iFranchise Holds Top Spot in Consulting for 8 Years

Updated Category News Views 4

iFranchise's Unyielding Dominance in Franchise Consulting Five seconds in the franchise game, and you'd know that staying on top is a grind. But when you're iFranchise Group, it seems like the eighth time is the charm—if there ever was a need for luck. These folks have secured the number one spot in Entrepreneur magazine's Top Franchise Suppliers ranking yet again....

Continue Reading
TerraMaster 725 NAS Unveils AI-Era Storage Solutions

Updated Category News Views 4

Tech Giants and Pioneers Rejoice Strap in, because TerraMaster just waved the green flag on their brand-new 725 Series Xeon Rackmount NAS, and it's high time the data storage world got a shake-up. Picture this: we're in the throes of an AI boom, and companies have data needs that gobble up yesterday's solutions with the hunger of a black hole. Well, enter TerraMaster's...

Continue Reading
Handshake Introduces AI Skills Studio at NYSE Event

Updated Category News Views 7

Shaking Up the Job Market with AI Skills What's shaking things up this time around? Handshake's dramatic unveiling of its AI Skills Studio, that's what. While the world spins on its financial axis, Handshake's showing up with a toolkit that's not just geeky gobbledygook. They're dead set on prepping job seekers with the nitty-gritty of AI know-how hosted in a rather...

Continue Reading
FBI Vet Marcus Thomas Joins Re-fined Nonprofit Board

Updated Category News Views 5

Remember the days when the FBI felt like a mythical fortress of surveillance and high-tech wizardry? Today, we're seeing one of its key veterans, Marcus Thomas, take a different path—a path that's as gritty and necessary as any Wall Street hustle. He's jumping onto the board of Re-fined, a Denver nonprofit aiming to give survivors of sexual exploitation and human...

Continue Reading
Dr. Sarah Leary Leads CBTN's Growth in Pediatric Oncology

Updated Category News Views 4

Pioneering Leadership for Children's Brain Tumor Network In a world where every advance in pediatric oncology can make a measurable difference, the Children's Brain Tumor Network (CBTN) has just unveiled quite the ace up its sleeve: Dr. Sarah Leary. She's stepping in as Co-Chair of its Executive Board, taking the reins alongside Brian Rood, MD. With extensive experience...

Continue Reading
GRAI's Innovative Play with Hangout FM in Streaming

Updated Category News Views 10

Reimagining Streaming: GRAI Buys Hangout FM The music streaming game has just been dealt a fresh hand. GRAI, an AI-driven music company, has snatched up Hangout FM, looking to ignite a social revolution in how we experience music. Sitting here, I'm thinking about all those playlists we've built but never truly shared. This acquisition might just change that by combining...

Continue Reading

Top 5 Most Recently Viewed Articles

Haemonetics Corporation's Key Insights from Healthcare Conference

Updated Category News Views 126

Haemonetics Corporation's Participation in Annual Healthcare Conference Haemonetics Corporation, a prominent player in the medical technology field, made headlines with their recent announcement regarding their participation in a significant annual healthcare conference. This event provides a vital platform for sharing innovative ideas and showcasing advancements in...

Continue Reading
Cellectar and ITM Unite to Enhance Cancer Treatment Innovation

Updated Category News Views 219

Cellectar Biosciences Partners with ITM for Cancer Treatment In a significant step towards improving cancer treatment options, Cellectar Biosciences, a prominent late-stage clinical biopharmaceutical company, has entered into a supply agreement with ITM Isotope Technologies Munich SE. This collaboration aims to bolster the clinical development of Cellectar's...

Continue Reading
Galectin Therapeutics Inc. Faces Investigation – What Investors Need to Know

Updated Category News Views 110

Investigation Launched for Galectin Therapeutics Investors In a recent development, the Pomerantz Law Firm is looking into potential claims on behalf of investors associated with Galectin Therapeutics Inc. (NASDAQ: GALT). This investigation raises crucial questions regarding the company's business practices and whether its executives may have been involved in any...

Continue Reading
Celebrating the Craft: Untappd 2nd Annual Community Awards

Updated Category News Views 255

Celebrating the Craft Beer Community The Untappd Community Awards have returned to honor the finest beers as voted by a dedicated community of craft beer enthusiasts. In 2024, over 25,000 incredible brews from more than 7,000 breweries worldwide were celebrated. With the growing international interest in craft beer, this year's awards promise to be even more spectacular...

Continue Reading
Spanish Mountain Gold Launches Effective Exploration Strategy

Updated Category News Views 90

Spanish Mountain Gold Unveils Its 2025 Winter Exploration Initiative Spanish Mountain Gold Ltd. (the "Company" or "Spanish Mountain Gold") (TSX-V: SPA) (FSE: S3Y) (OTCQB: SPAZF) is thrilled to announce the launch of its 2025 winter exploration diamond drill program at the Spanish Mountain Gold Project. This significant initiative is designed to enhance mineral extraction...

Continue Reading